{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:15:55Z","timestamp":1791288955026,"version":"4.3.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetes is one of the quickest-growing global health emergencies of the twenty-first century, and data-driven care can improve the quality of diabetes management. We aimed to describe the formation of a 10-year retrospective open cohort of type 2 diabetes patients in Malaysia. We also described the baseline treatment profiles and HbA1c, blood pressure, and lipid control to assess the quality of diabetes care. We used 10 years of cross-sectional audit datasets from the National Diabetes Registry and merged 288,913 patients with the same identifying information into a 10-year open cohort dataset. Treatment targets for HbA1c, blood pressure, LDL-cholesterol, HDL-cholesterol, and triglycerides were based on Malaysian clinical practice guidelines. IBM SPSS Statistics version 23.0 was used, and frequencies and percentages with 95% confidence intervals were reported. In total, 288,913 patients were included, with 62.3% women and 54.1% younger adults. The commonest diabetes treatment modality was oral hypoglycaemic agents (75.9%). Meanwhile, 19.3% of patients had\u2009\u2265\u20093 antihypertensive agents, and 71.2% were on lipid-lowering drugs. Metformin (86.1%), angiotensin-converting enzyme inhibitors (49.6%), and statins (69.2%) were the most prescribed antidiabetic, antihypertensive, and lipid-lowering medications, respectively. The mean HbA1c was 7.96\u2009\u00b1\u20092.11, and 31.2% had HbA1c\u2009&gt;\u20098.5%. Only 35.8% and 35.2% attained blood pressure\u2009&lt;\u2009140\/80\u00a0mmHg and LDL-cholesterol\u2009&lt;\u20092.6\u00a0mmol\/L, respectively. About 57.5% and 52.9% achieved their respective triglyceride and HDL-cholesterol goals. In conclusion, data integration is a feasible method in this diabetes registry. HbA1c, blood pressure, and lipids are not optimally controlled, and these findings can be capitalized as a guideline by clinicians, programme managers, and health policymakers to improve the quality of diabetes care and prevent long-term complications in Malaysia.<\/jats:p>","DOI":"10.1038\/s41598-023-44564-y","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T10:02:17Z","timestamp":1697191337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Baseline treatments and metabolic control of 288,913 type 2 diabetes patients in a 10-year retrospective cohort in Malaysia"],"prefix":"10.1038","volume":"13","author":[{"given":"Kim Sui","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feisul","family":"Mustapha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunah","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubash Shander","family":"Ganapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhaliza","family":"Zakariah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivarajan","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunenthira Rao","family":"Subbarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Fadhli","family":"Mohd Yusoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"44564_CR1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas 10th edition. (2021)."},{"key":"44564_CR2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabet. Res. Clin. Pract. 183, 109119 (2022).","journal-title":"Diabet. Res. Clin. Pract."},{"key":"44564_CR3","volume-title":"Twelfth Malaysia Plan 2021\u20132025","author":"Economic Planning Unit Prime Minister's Department","year":"2021","unstructured":"Economic Planning Unit Prime Minister\u2019s Department. Twelfth Malaysia Plan 2021\u20132025 (Putrajaya, 2021)."},{"issue":"10267","key":"44564_CR4","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","volume":"396","author":"JCN Chan","year":"2020","unstructured":"Chan, J. C. N. et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. The Lancet. 396(10267), 2019\u20132082 (2020).","journal-title":"The Lancet."},{"key":"44564_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-319-13389-8_5","volume-title":"Integrated Diabetes Care: A Multidisciplinary Approach","author":"RO Yeung","year":"2017","unstructured":"Yeung, R. O., Yin, J. & Chan, J. C. N. Integrated Diabetes Care in Hong Kong: From Research to Practice to Policy. In Integrated Diabetes Care: A Multidisciplinary Approach (eds Simmons, D. et al.) 65\u201385 (Springer, 2017)."},{"key":"44564_CR6","unstructured":"Ministry of Health Malaysia. National Diabetes Registry Report 2013 - 2019. (2020)."},{"key":"44564_CR7","unstructured":"Ministry of Health Malaysia. User Manual Quality of Diabetes Care at MOH Healthcare Facilities: Glycaemic Control. (2008)."},{"issue":"11","key":"44564_CR8","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/1753-0407.13206","volume":"13","author":"KS Wan","year":"2021","unstructured":"Wan, K. S., Moy, F. M., Mustapha, F. I., Ismail, M. & Hairi, N. N. Changes in body mass index, glycosylated hemoglobin A1C, blood pressure, and LDL-cholesterol among type 2 diabetes patients in Malaysia: A population-based longitudinal study. J. Diabet. 13(11), 915\u2013929 (2021).","journal-title":"J. Diabet."},{"key":"44564_CR9","unstructured":"Rothman, K.J., Greenland, S., & Lash, T.L. Modern epidemiology. (2008)."},{"key":"44564_CR10","unstructured":"Institute for Public Health. National Health and Morbidity Survey (NHMS) 2019: Vol 1: NCDs\u2014Non-communicable Diseases: Risk Factors and other Health Problems. (2020)."},{"issue":"6","key":"44564_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1177\/0013164416664117","volume":"77","author":"KM Marcoulides","year":"2017","unstructured":"Marcoulides, K. M. & Grimm, K. J. Data integration approaches to longitudinal growth modeling. Educ. Psychol. Meas. 77(6), 971\u2013989 (2017).","journal-title":"Educ. Psychol. Meas."},{"issue":"2","key":"44564_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/dme.14044","volume":"37","author":"JMM Rumbold","year":"2020","unstructured":"Rumbold, J. M. M., O\u2019Kane, M., Philip, N. & Pierscionek, B. K. Big Data and diabetes: The applications of Big Data for diabetes care now and in the future. Diabet. Med. 37(2), 187\u2013193 (2020).","journal-title":"Diabet. Med."},{"key":"44564_CR13","unstructured":"United Nations. World Population Ageing 2015 - Highlight. (2015)."},{"issue":"6","key":"44564_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41574-020-0334-z","volume":"16","author":"DJ Magliano","year":"2020","unstructured":"Magliano, D. J. et al. Young-onset type 2 diabetes mellitus\u2014Implications for morbidity and mortality. Nature Rev. Endocrinol. 16(6), 321\u2013331 (2020).","journal-title":"Nature Rev. Endocrinol."},{"key":"44564_CR15","unstructured":"Ministry of Health Malaysia. Clinical Practice Guidelines on Management of Obesity. 2004."},{"issue":"9403","key":"44564_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"World Health Organization Expert Consultation","year":"2004","unstructured":"World Health Organization Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet. 363(9403), 157\u2013163 (2004).","journal-title":"The Lancet."},{"issue":"1","key":"44564_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon, N., Shakib, S., Kalisch-Ellett, L. & Caughey, G. E. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 17(1), 230 (2017).","journal-title":"BMC Geriatr."},{"key":"44564_CR18","unstructured":"Ministry of Health Malaysia. Clinical practice guidelines. Management of type 2 diabetes mellitus. (6th edition). (2020)."},{"key":"44564_CR19","unstructured":"International Diabetes Federation. Recommendations for Managing Type 2 Diabetes in Primary Care. (2017)."},{"key":"44564_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2017.12.004","volume":"137","author":"K Khunti","year":"2018","unstructured":"Khunti, K., Ceriello, A., Cos, X. & De Block, C. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis. Diabet. Res. Clin. Pract. 137, 137\u2013148 (2018).","journal-title":"Diabet. Res. Clin. Pract."},{"issue":"1","key":"44564_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach, F. et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur. Heart J. 41(1), 111\u2013188 (2020).","journal-title":"Eur. Heart J."},{"issue":"10","key":"44564_CR22","doi-asserted-by":"publisher","first-page":"e0275920","DOI":"10.1371\/journal.pone.0275920","volume":"17","author":"JK Tan","year":"2022","unstructured":"Tan, J. K. et al. Trends in diabetes-related complications in Singapore, 2013\u20132020: A registry-based study. PLoS ONE. 17(10), e0275920 (2022).","journal-title":"PLoS ONE."},{"issue":"19","key":"44564_CR23","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1161\/CIRCULATIONAHA.118.037885","volume":"139","author":"N Sattar","year":"2019","unstructured":"Sattar, N. et al. Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks. Circulation 139(19), 2228\u20132237 (2019).","journal-title":"Circulation"},{"issue":"12","key":"44564_CR24","first-page":"3641","volume":"50","author":"KS Wan","year":"2021","unstructured":"Wan, K. S. et al. Poorer attainment of hemoglobin A1C, blood pressure and LDL-cholesterol goals among Younger adults with type 2 diabetes. Sains Malays. 50(12), 3641\u20133645 (2021).","journal-title":"Sains Malays."},{"issue":"1","key":"44564_CR25","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.1038\/s41598-021-86277-0","volume":"11","author":"KS Wan","year":"2021","unstructured":"Wan, K. S. et al. Predictors of glycosylated haemoglobin A1C trend among type 2 diabetes patients in a multi-ethnic country. Sci. Rep. 11(1), 6803 (2021).","journal-title":"Sci. Rep."},{"issue":"6","key":"44564_CR26","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/dom.13243","volume":"20","author":"K Khunti","year":"2018","unstructured":"Khunti, K., Kosiborod, M. & Ray, K. K. Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?. Diabet. Obes. Metabolism. 20(6), 1337\u20131341 (2018).","journal-title":"Diabet. Obes. Metabolism."},{"issue":"2","key":"44564_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.5455\/msm.2013.25.140-142","volume":"25","author":"MA Siddiqui","year":"2013","unstructured":"Siddiqui, M. A., Khan, M. F. & Carline, T. E. Gender differences in living with diabetes mellitus. Mater Sociomed. 25(2), 140\u2013142 (2013).","journal-title":"Mater Sociomed."},{"issue":"21","key":"44564_CR28","doi-asserted-by":"publisher","first-page":"14251","DOI":"10.3390\/ijerph192114251","volume":"19","author":"M Alser","year":"2022","unstructured":"Alser, M. & Elrayess, M. A. From an apple to a pear: Moving fat around for reversing insulin resistance. Int. J. Environ. Res. Public Health. 19(21), 14251 (2022).","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"44564_CR29","unstructured":"Ministry of Health Malaysia. Ministry of Health Medicines Formulary (MOHMF). https:\/\/www.pharmacy.gov.my\/v2\/en\/documents\/ministry-health-medicines-formulary-mohmf.html. Published 2022. Updated 9 November 2022. Accessed 8 January 2022."},{"issue":"2","key":"44564_CR30","first-page":"229","volume":"76","author":"AM Gafoor","year":"2021","unstructured":"Gafoor, A. M. et al. Patient and procedure selection for bariatric and metabolic surgery in Malaysia\u2014The Malaysian Consensus. Med. Malays. 76(2), 229\u2013232 (2021).","journal-title":"Med. Malays."},{"issue":"5","key":"44564_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cjca.2020.02.066","volume":"36","author":"AA da Silva","year":"2020","unstructured":"da Silva, A. A. et al. Role of hyperinsulinemia and insulin resistance in hypertension: Metabolic syndrome revisited. Can. J. Cardiol. 36(5), 671\u2013682 (2020).","journal-title":"Can. J. Cardiol."},{"issue":"10","key":"44564_CR32","doi-asserted-by":"publisher","first-page":"e0223383","DOI":"10.1371\/journal.pone.0223383","volume":"14","author":"SS Syed Soffian","year":"2019","unstructured":"Syed Soffian, S. S. et al. Management and glycemic control of patients with type 2 diabetes mellitus at primary care level in Kedah, Malaysia: A statewide evaluation. PLoS ONE 14(10), e0223383 (2019).","journal-title":"PLoS ONE"},{"issue":"12","key":"44564_CR33","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00125-014-3369-7","volume":"57","author":"S Zoungas","year":"2014","unstructured":"Zoungas, S. et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 57(12), 2465\u20132474 (2014).","journal-title":"Diabetologia."},{"issue":"1","key":"44564_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.15256\/joc.2016.6.72","volume":"6","author":"R Navickas","year":"2016","unstructured":"Navickas, R., Petric, V. K., Feigl, A. B. & Seychell, M. Multimorbidity: What do we know? What should we do?. J. Comorb. 6(1), 4\u201311 (2016).","journal-title":"J. Comorb."},{"issue":"1","key":"44564_CR35","first-page":"98","volume":"3","author":"I Mastura","year":"2011","unstructured":"Mastura, I. et al. Control and treatment profiles of 70,889 adult type 2 diabetes mellitus patients in Malaysia\u2014A cross sectional survey in 2009. Int. J. Collab. Res. Intern. Med. & Public Health. 3(1), 98\u2013113 (2011).","journal-title":"Int. J. Collab. Res. Intern. Med. & Public Health."},{"issue":"2","key":"44564_CR36","first-page":"10","volume":"13","author":"C Goh","year":"2018","unstructured":"Goh, C., Koh, K., Goh, S., Koh, Y. & Tan, N. Achieving triple treatment goals in multi-ethnic Asian patients with type 2 diabetes mellitus in primary care. Malays. Family Phys. Off. J. Acad. Family Phys. Malays. 13(2), 10 (2018).","journal-title":"Malays. Family Phys. Off. J. Acad. Family Phys. Malays."},{"key":"44564_CR37","first-page":"50","volume":"2012","author":"C Jimeno","year":"2008","unstructured":"Jimeno, C., Sobrepe\u00f1a, L. & DiabCare, M. R. Survey on glycaemic control and the status of diabetes care and complications among patients with type 2 diabetes mellitus in the philippines. Phillippine J. Intern. Med. 2012, 50 (2008).","journal-title":"Phillippine J. Intern. Med."},{"issue":"1","key":"44564_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3329\/bmrcb.v37i1.7793","volume":"37","author":"ZA Latif","year":"2011","unstructured":"Latif, Z. A., Jain, A. & Rahman, M. M. Evaluation of management, control, complications and psychosocial aspects of diabetics in Bangladesh: DiabCare Bangladesh 2008. Bangladesh Med. Res. Counc. Bull. 37(1), 11\u201316 (2011).","journal-title":"Bangladesh Med. Res. Counc. Bull."},{"key":"44564_CR39","first-page":"48","volume":"65","author":"J Mokta","year":"2017","unstructured":"Mokta, J., Mokta, K., Ranjan, A. & Garg, M. Prevalence of cardiovascular risk factors among diabetic population and awareness of diabetes among diabetic patients: A population based himalayan study. J. Assoc. Physicians India 65, 48 (2017).","journal-title":"J. Assoc. Physicians India"},{"issue":"4","key":"44564_CR40","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jyp.2013.11.006","volume":"5","author":"SS Alavudeen","year":"2013","unstructured":"Alavudeen, S. S., Dhanapal, C. K., Khan, N. A., Al Akhali, K. M. & Paulliah, S. D. Prevalence and control of cardiovascular risk factors among type 2 diabetes mellitus patients in southern region of Saudi Arabia. J. Young Pharm. 5(4), 144\u2013147 (2013).","journal-title":"J. Young Pharm."},{"issue":"7","key":"44564_CR41","doi-asserted-by":"publisher","first-page":"e0159071","DOI":"10.1371\/journal.pone.0159071","volume":"11","author":"H Hu","year":"2016","unstructured":"Hu, H. et al. Hba1c, blood pressure, and lipid control in people with diabetes: Japan Epidemiology Collaboration on Occupational Health Study. PLoS ONE 11(7), e0159071 (2016).","journal-title":"PLoS ONE"},{"issue":"8","key":"44564_CR42","doi-asserted-by":"publisher","first-page":"e006400","DOI":"10.1161\/JAHA.117.006400","volume":"6","author":"EYF Wan","year":"2017","unstructured":"Wan, E. Y. F. et al. Effect of multifactorial treatment targets and relative importance of hemoglobin A1c, blood pressure, and low-density lipoprotein-cholesterol on cardiovascular diseases in chinese primary care patients with type 2 diabetes mellitus: A population-based retrospective cohort study. J. Am. Heart Assoc. 6(8), e006400 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"44564_CR43","doi-asserted-by":"publisher","first-page":"f360","DOI":"10.1136\/bmj.f360","volume":"346","author":"H Makani","year":"2013","unstructured":"Makani, H., Bangalore, S., Desouza, K. A., Shah, A. & Messerli, F. H. Efficacy and safety of dual blockade of the renin-angiotensin system: Meta-analysis of randomised trials. BMJ. 346, f360 (2013).","journal-title":"BMJ."},{"issue":"12","key":"44564_CR44","doi-asserted-by":"publisher","first-page":"e008073","DOI":"10.1136\/bmjopen-2015-008073","volume":"5","author":"SMC Ament","year":"2015","unstructured":"Ament, S. M. C. et al. Sustainability of professionals\u2019 adherence to clinical practice guidelines in medical care: A systematic review. BMJ Open. 5(12), e008073 (2015).","journal-title":"BMJ Open."},{"issue":"2","key":"44564_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jdiacomp.2012.02.006","volume":"26","author":"P Sudchada","year":"2012","unstructured":"Sudchada, P. et al. Diabetes and cardiovascular risk factor controls in Thai type 2 diabetes with no history of cardiovascular complications; situation and compliance to diabetes management guideline in Thailand. J. Diabetes Complic. 26(2), 102\u2013106 (2012).","journal-title":"J. Diabetes Complic."},{"key":"44564_CR46","doi-asserted-by":"publisher","first-page":"e13816","DOI":"10.7717\/peerj.13816","volume":"10","author":"KS Wan","year":"2022","unstructured":"Wan, K. S. et al. 5-year LDL-cholesterol trend and its predictors among type 2 diabetes patients in an upper-middle-income country: A retrospective open cohort study. PeerJ. 10, e13816 (2022).","journal-title":"PeerJ."},{"issue":"10","key":"44564_CR47","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/jama.2016.0299","volume":"315","author":"KJ Lipska","year":"2016","unstructured":"Lipska, K. J., Krumholz, H., Soones, T. & Lee, S. J. Polypharmacy in the aging patient: A review of glycemic control in older adults with type 2 diabetes. JAMA. 315(10), 1034\u20131045 (2016).","journal-title":"JAMA."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44564-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44564-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44564-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T22:09:28Z","timestamp":1700604568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44564-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["44564"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-44564-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"24 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17338"}}